Cardiovasc Prev Pharmacother > v.7(3)

5 results

61 Glucagon-like peptide-1 receptor agonists improve cholesterol metabolism by inhibiting SREBP-2 via SIRT6-AMPK pathway in HepG2 cells treated with palmitic acid
Jinmi Lee, Eun-Jung Rhee, Yu-Mi Lim, Seok-Woo Hong, Won-Young Lee
KMSID: 1516092304   Cardiovasc Prev Pharmacother. 2025;7(3):61-72.   Published online 2025 July 24    DOI: http://dx.doi.org/10.36011/cpp.2025.7.e11
      
73 The distribution of artificial intelligence–derived retinal cardiovascular risk scores and conventional risk factors in two Korean health screening cohorts: a descriptive study
Jungkyung Cho, Jaewon Seo, Junseok Park, Dongjin Nam, Tae Hyun Park, Sahil Thakur, Tyler Hyungtaek Rim, Beom-hee Choi, Miso Jang
KMSID: 1516092307   Cardiovasc Prev Pharmacother. 2025;7(3):73-84.   Published online 2025 July 28    DOI: http://dx.doi.org/10.36011/cpp.2025.7.e14
      
85 2024 Cardio-cerebrovascular disease fact sheet in Korea
Kyungdo Han, Jin-Hyung Jung, Sang-Suk Choi, Seung-Hyun Ko
KMSID: 1516092306   Cardiovasc Prev Pharmacother. 2025;7(3):85-93.   Published online 2025 July 29    DOI: http://dx.doi.org/10.36011/cpp.2025.7.e13
      
94 Stroke mechanisms and prevention in intracranial atherosclerosis
Sang Hee Ha, Bum Joon Kim
KMSID: 1516092303   Cardiovasc Prev Pharmacother. 2025;7(3):94-101.   Published online 2025 July 22    DOI: http://dx.doi.org/10.36011/cpp.2025.7.e10
      
102 Zilebesiran: an RNA therapeutic agent interfering with angiotensinogen synthesis
Woong Gil Choi
KMSID: 1516092305   Cardiovasc Prev Pharmacother. 2025;7(3):102-108.   Published online 2025 July 25    DOI: http://dx.doi.org/10.36011/cpp.2025.7.e12
      
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap